March 2024

New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD ()
Cardiologists see value in AI-based plaque assessments ()
Donor hearts more likely to be accepted when the transplant candidate is female or white ()
Cardiologists received $1.3B in industry payments over 10-year period, No. 3 among all healthcare specialties ()
FDA approves Medtronic’s next-generation TAVR system with new frame design ()
Heart attacks after TAVR: New AMI data ‘reassuring’ at first glance, but questions remain ()
Microplastics in carotid plaques increase risk of adverse cardiovascular outcomes ()
New data registry will track how AI-powered plaque assessments impact cardiologist decisions ()
FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck ()
Report: Johnson & Johnson once again considering deal to acquire Shockwave Medical ()
Hospital accused of implanting experimental heart valve in young patient without proper consent ()
TAVR is often more cost-effective than SAVR—but not always ()
Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke ()
SPECT still has an important role to play in nuclear cardiology ()
VR before TAVR predicts paravalvular leak in high-risk patients ()
Biosense Webster takes key step toward FDA approval for Varipulse PFA system ()
Novo Nordisk to acquire biotech company working on new heart failure drug for $1.1B ()
ACC.24 to make the business side of cardiology a priority ()
Medicare will now cover weight loss drug semaglutide if taken for heart benefits ()
Going green in the cath lab makes economic sense ()
FDA grants new implant for BTK arterial disease its breakthrough device designation ()
A possible remedy for cardiology’s staffing shortages: heart failure internists ()
FDA announces new recall impacting more than 66,000 Impella heart pumps after 49 deaths ()
‘Highly effective’: COVID-19 vaccines reduced risk of heart failure, other cardiovascular complications after infection ()
FDA approves new hypertension drug months after Idorsia reacquired rights for $343M ()
New DCD heart transplant technique could reduce risk of serious injury ()
Interventional techniques can help limit amputations among CLI patients ()
Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system ()
Intermittent fasting may increase risk of death from heart attack, stroke ()
Doctors form new coalition focused on reducing private equity’s role in cardiology, other healthcare specialties ()
Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease ()
FDA grants new resorbable scaffold for CLTI its breakthrough device designation ()
Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease ()
Edwards, Abbott share updated TAVR data at CRT 2024 ()
Cardiologist shares his long journey from Libya to United States ()
Too much niacin? Excess vitamin B3 may increase risk of heart attack, stroke ()
Peripheral artery disease is out of control in many rural, low income communities ()
New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs ()
Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB ()
Most physicians think private equity is bad for healthcare ()
Coronary Artery Disease in Women: Utilizing CCTA to Make an Accurate Diagnosis ()
Cognitive impairment among heart failure patients: How cardiologists can help ()
Cardiologist urges cath labs to adopt radiation shields: ‘It is time to protect ourselves’ ()
Heart issues more common in adults who drink soda, other sweetened beverages ()
AI-based CAD assessments as accurate as FFR, new 10-year study confirms ()
TAVR vs. SAVR: Medtronic’s Evolut platform linked to cost savings, key benefits for low-risk patients ()
Heart health experts explore CT’s role in the diagnosis of CAD in women ()
Abbott recalls device for tracking LVAD data after 8 injuries ()
ACC, SCAI say new funding bill did not do enough to limit Medicare reimbursement cuts to cardiology services ()
Vascular ‘paint’ for heart patients earns researchers $2.8M in funding ()
A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks ()
Most cardiologists would take a lower salary for a better work-life balance ()
Swiss startup targets stroke patients with first US install of robotics system for remote vascular interventions ()
Some older patients taking aspirin to prevent CVD may be doing more harm than good ()
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do ()
FDA announces new Class I recall of drainage systems after 26 injuries ()
Coronary calcium scoring predicts when chest pain patients can skip invasive testing ()
FDA clears first over-the-counter wearable device for continuous glucose monitoring ()
TMVR vs. mitral valve surgery: Tendyne linked to improved survival in elderly patients ()
FDA grants AI software for imaging-based heart assessments its breakthrough device designation ()
Permanent pacemaker implantation after TAVR increases healthcare costs by $24,000 per patient ()
Private equity-backed cardiology management group expands its leadership team ()
How a big CMS update on carotid stenting could impact interventional cardiology ()
Ultra-processed foods linked to 32 adverse health outcomes, including CVD-related death and diabetes ()
Family man from Netherlands named world’s longest-surviving heart transplant recipient ()
‘Just like smoking tobacco’: Cannabis use increases stroke risk by 42%, heart attack risk by 25% ()
Healthcare fraud: DOJ recovered $1.9B in 2023, including several key settlements related to cardiology ()
FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis ()
The many benefits of using low-cost CT coronary calcium scoring to screen patients ()